
Unlocking the Future of Alzheimer’s Care: Transforming Dementia Treatment for the Next Generation
In November of 2022, pharmaceutical company Eisai released the results of Alzheimer’s treatment, lecanemab, with hopes of tackling and reducing the effects of Alzehmiers rather